Publications in collaboration with researchers from Instituto de Investigación Biomédica de Salamanca (45)

2024

  1. An algorithm for the diagnosis of betalactam allergy, 2024 update

    Allergy: European Journal of Allergy and Clinical Immunology

  2. Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3

    Biomedicine and Pharmacotherapy, Vol. 180

2023

  1. Characterization of three predicted zinc exporters in Brucella ovis identifies ZntR-ZntA as a powerful zinc and cadmium efflux system not required for virulence and unveils pathogenic Brucellae heterogeneity in zinc homeostasis

    Frontiers in Veterinary Science, Vol. 10

  2. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)

    Leukemia

  3. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Leukemia, Vol. 37, Núm. 2, pp. 339-347

  4. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  5. Management of patients with suspected or confirmed antibiotic allergy. Executive summary of guidance from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 181-186

  6. The most prominent modulated Annexins during parasitic infections

    Acta Tropica, Vol. 243

2022

  1. Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

    Neurologia, Vol. 37, Núm. 5, pp. 390-402

  2. Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 27, pp. 3151-3161

  3. Host cell proteins modulated upon Toxoplasma infection identified using proteomic approaches: a molecular rationale

    Parasitology Research, Vol. 121, Núm. 7, pp. 1853-1865

  4. Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

    Blood cancer journal, Vol. 12, Núm. 2, pp. 32

  5. Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma

    Blood Advances, Vol. 6, Núm. 11, pp. 3234-3239

  6. Mining the Proteome of Toxoplasma Parasites Seeking Vaccine and Diagnostic Candidates

    Animals, Vol. 12, Núm. 9

  7. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  8. Selenium and protozoan parasitic infections: selenocompounds and selenoproteins potential

    Parasitology Research, Vol. 121, Núm. 1, pp. 49-62

  9. The Defensive Interactions of Prominent Infectious Protozoan Parasites: The Host’s Complement System

    Biomolecules, Vol. 12, Núm. 11

  10. miRNAs in the regulation of mTOR signaling and host immune responses: The case of Leishmania infections

    Acta Tropica, Vol. 231

2021

  1. Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study

    Modern Pathology, Vol. 34, Núm. 1, pp. 59-69

  2. B-cell regeneration profile and minimal residual disease status in bone marrow of treated multiple myeloma patients

    Cancers, Vol. 13, Núm. 7